vancomycin has been researched along with beta-lactams in 182 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (2.20) | 18.7374 |
| 1990's | 8 (4.40) | 18.2507 |
| 2000's | 42 (23.08) | 29.6817 |
| 2010's | 90 (49.45) | 24.3611 |
| 2020's | 38 (20.88) | 2.80 |
| Authors | Studies |
|---|---|
| Moellering, RC | 1 |
| Eich, G; Neftel, KA | 1 |
| Klein, U; Opferkuch, W; Pawelzik, M | 1 |
| Moosdeen, F; Raimondi, A; Williams, JD | 1 |
| Garau, J; Liñares, J; Martín, R; Murgui, L; Perez, JL | 1 |
| Traub, WH | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y; Yokota, N | 1 |
| Barbadora, K; Binczewski, B; Edmund, M; Green, M; Kusne, S; Pasculle, AW; Shlaes, DM | 1 |
| Cabellos, C; Liñares, J; Tuban, F | 1 |
| Cabibbo, E; Corulli, M; Dima, F; Fallacara, C; Longo, M; Peroni, L; Pizzi, R; Pollara, PC; Ravizzola, G; Turano, A | 1 |
| Archer, GL; Climo, MW; Patron, RL | 1 |
| Barba, MA; Blas, JJ; Crespo, MD; Escribano, E; Fernández, T; Yeste, F | 1 |
| Caron, F; Lemeland, JF; Pestel-Caron, M; Rochon-Edouard, S | 1 |
| Chin, KG; Mactal-Haaf, C; McPherson, CE | 1 |
| Aritaka, N; Cui, L; Hanaki, H; Hiramatsu, K | 1 |
| Bonner, D; Fung-Tomc, J; Gradelski, E; Kolek, B; Valera, L | 1 |
| Slatore, CG; Tilles, SA | 1 |
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Pfister, M; Täuber, MG | 1 |
| Hanaki, H; Yamaguchi, Y | 1 |
| Barada, K; Hanaki, H; Inamatu, T; Sunakawa, K; Yamaguchi, Y | 1 |
| Hanaki, H; Haraga, I; Nagayama, A; Nomura, S; Sunakawa, K; Yamaguchi, Y | 1 |
| Athamna, A; Athamna, M; Bast, DJ; Medlej, B; Rubinstein, E | 1 |
| Atoui, R; Ben Ali, A; Goldstein, FW; Kitzis, MD; Ly, A; Nguyen, JC | 1 |
| Hanaki, H; Hatano, K; Sunagawa, K; Yokota, Y | 1 |
| Dower, SK; Moore, LJ; Pridmore, AC; Read, RC | 1 |
| Hanaki, H | 2 |
| Hanaki, H; Hayashi, I; Hososaka, Y; Kamibeppu, K; Sunakawa, K | 1 |
| Aksoy, A; Kaçmaz, B | 1 |
| Brøsen, K; Frimodt-Møller, N; Gahrn-Hansen, B; Madsen, H | 1 |
| Chapman, AL; Greig, JM; Innes, JA | 1 |
| Bal, AM; Gould, IM | 1 |
| Fakih, MG; Johnson, LB; Khatib, R; Riederer, K; Saeed, S; Sharma, M | 1 |
| Appelbaum, PC | 1 |
| Hanaki, H; Hatano, K; Sunakawa, K; Yokota, Y | 1 |
| Lipman, J; Roberts, JA | 1 |
| Leaños-Miranda, BE; Miranda-Novales, G; Solórzano-Santos, F; Vilchis-Pérez, M | 1 |
| Anastasopoulos, T; Kofteridis, DP; Kontopodis, E; Panagiotakis, S; Samonis, G | 1 |
| Li, JT; Markus, P; Matesic, D; Park, M | 1 |
| García-Rodríguez, JA; Muñoz Bellido, JL | 1 |
| Hassoun, A | 1 |
| Chatterjee, I; Iredell, JR; Lipman, J; Woods, M | 1 |
| Lartigue, MF; Nordmann, P; Poirel, L; Poyart, C; Réglier-Poupet, H | 1 |
| Bauer, F; Benca, J; Beno, P; Huttova, M; Kisac, P; Kovac, M; Ondrusova, A; Rudinsky, B; Sramka, M | 1 |
| De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L | 1 |
| Choe, KW; Kim, EC; Kim, HB; Kim, KH; Kim, NJ; Kim, SH; Oh, MD | 1 |
| Hanaki, H; Ikeda, S; Matsui, H; Nakae, T; Sunakawa, K; Yanagisawa, C | 1 |
| Ahsman, MJ; Mathot, RA; Tibboel, D; Wildschut, ED | 1 |
| Cui, L; Hiramatsu, K; Katayama, Y; Murakami-Kuroda, H | 1 |
| Kusaba, K; Manome, I; Nagasawa, Z; Nagayama, A; Nakashima, Y; Oho, M | 1 |
| Leibovici, L; Paul, M; Svetitsky, S | 1 |
| Archer, GL; Higgins, PG; Rosato, AE; Seifert, H; Wisplinghoff, H | 1 |
| Baddour, LM; Fadel, HJ; Steckelberg, JM; Tleyjeh, IM; Wilson, WR | 1 |
| Hagane, K; Hanaki, H; Hashimoto, T; Ikeda-Dantsuji, Y; Ishizaki, A; Kageyama, Y; Kawaguchi, T; Kawajiri, H; Ono, T; Sato, S; Sugahara, K; Sunakawa, K; Tachihara-Sato, R; Takahashi, Y; Tamura, A; Yamaguchi, Y; Yanagisawa, C; Yanagisawa, T; Yazaki, H | 1 |
| Berbari, EF; Fadel, H; Kohner, PC; Mabry, T; Osmon, DR; Patel, R; Shah, NB; Steckelberg, JM | 1 |
| Avison, MB; Ayala, JA; Baker, JA; Bennett, PM; Niumsup, P; Tayler, AE; Walsh, TR; Westphal, K; Wiedemann, B; Zhang, L | 1 |
| Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S; Schechner, V; Schwaber, MJ | 1 |
| Agrafiotis, M; Drapeau, CM; Falagas, ME; Petrosillo, N | 1 |
| Galanakis, E; Maraki, S; Samonis, G | 1 |
| Gonzalez-Granado, LI | 1 |
| Chu, CC; Hsueh, PR; Huang, YT; Lai, CC; Lee, PI; Lee, YL; Lu, CL; Tan, CK; Wang, CY | 1 |
| Bishara, J; Leibovici, L; Lev, B; Lishtzinsky, Y; Paul, M; Samra, Z; Talker, O; Zemer-Wassercug, N | 1 |
| Balada-Llasat, JM; Buckosh, M; Hemminger, J; Pancholi, P; Raczkowski, M | 1 |
| Garg, S; Marrie, TJ; Tyrrell, GJ; Vanderkooi, OG | 1 |
| Beekmann, SE; Hersh, AL; Newland, JG; Polgreen, PM; Shah, SS; Shapiro, DJ | 1 |
| Lemonovich, TL; Watkins, RR | 1 |
| Aguado, JM; Chaves, F; Gómez-Gonzalez, C; Lalueza, A; Rodríguez-Otero, J; San-Juan, R; Sanz, F | 1 |
| Ashley, ED; Brown, J; Brown, K; Butterfield, JM; Forrest, A; Hardy, D; Lodise, TP; Tsuji, BT | 1 |
| Lu, CD; Yao, X | 1 |
| Abdelali, S; Abdelouahid, DE; Azzaoui, H; Rahmoun, M; Rebiahi, SA | 1 |
| Bayer, AS; Mishra, NN; Moise, PA; Nizet, V; Pogliano, J; Sakoulas, G; Tsuji, BT; Yang, SJ; Yeaman, MR | 1 |
| Bathina, P; Bheemreddy, S; Chalana, IK; Hasan, A; Hayakawa, K; Kamatam, S; Kaye, KS; Kotra, H; Ku, K; Kumar, S; Lee, DW; Lephart, PR; Marchaim, D; Martin, ET; Nanjireddy, P; Patel, S; Pogue, JM; Pulluru, H; Rybak, MJ; Sheth, P; Sunkara, B; Swan, J; Tiwari, N; Vahia, A; Yee, V; Yousuf, A | 1 |
| Fleer, A; Hemels, MA; Krediet, TG; Paauw, A | 1 |
| Hanaki, H; Hirao, Y; Hori, S; Ikeda-Dantsuji, Y; Matsui, H; Nakae, T; Sunakawa, K; Yoshida, M | 1 |
| Ezoe, T; Ishiyama, M; Matsumoto, K; Noguchi, K; Shiga, M; Suenaga, H; Tsukatani, T | 1 |
| Bull, AL; Richards, MJ; Worth, LJ | 1 |
| Costero-Fernández, O; Díaz-Mancebo, R; Olea-Tejero, T; Picazo, ML; Selgas-Gutiérrez, R; Vega-Cabrera, C; Yébenes, L | 1 |
| Colton, BJ; George, JM; Rodvold, KA | 1 |
| Bonomo, RA; Donskey, CJ; Drawz, PE; Hirsch, AA; Jump, RL; Jury, LA; Kypriotakis, G; Olds, DM; Peron, EP; Seifi, N; Watts, B | 1 |
| Inokoshi, J; Koyama, N; Tomoda, H | 1 |
| Buyle, FM; Claeys, G; De Waele, J; Decruyenaere, J; Depuydt, P; Robays, H; Tulkens, PM; Van Audenrode, T; Vogelaers, D | 1 |
| Alvarez-Rocha, L; Arias, J; Azanza, JR; Barberán, J; Candel, F; de Alarcón, CA; Fortún, J; García, JE; Gómez, J; Grau, S; Llinares, P; Marco, F; Maseda, E; Mensa, J; Montejo, M; Moreno, A; Parra, J; Pasquau, J; Picazo, J; Salavert, M; Soriano, A; Soy, D | 1 |
| Bleasdale, SC; McConeghy, KW; Rodvold, KA | 1 |
| Keynan, Y; Rubinstein, E | 1 |
| Dilworth, TJ; Hall, P; Ibrahim, O; Mercier, RC; Sliwinski, J; Walraven, C | 1 |
| Berger, C; Boggian, K; Bucheli, E; Cusini, A; Garzoni, C; Khanna, N; Koller, MT; Kralidis, G; Manuel, O; Meylan, PR; Mueller, NJ; van Delden, C; Weisser, M | 1 |
| Cleveland, KO; Gelfand, MS; Mazumder, SA | 1 |
| Castaing, N; Cooper, A; Dartois, N; Dukart, G; Embil, JM; Lauf, L; Maroko, R; Mitha, I; Ozsvár, Z; Regöly-Mérei, J; Sabol, MB; Yan, J | 1 |
| Akers, KS; Hardy, SK; Murray, CK; Romano, DR; Sanchez, CJ; Wenke, JC; Woodbury, RL | 1 |
| Kees, F; Kees, MG; Kratzer, A; Liebchen, U; Schleibinger, M | 1 |
| Bes, M; Clair, P; Dauwalder, O; Dumitrescu, O; Freydière, AM; Laurent, F; Martra, A; Reix, P; Renzoni, A; Reverdy, ME; Roch, M; Vandenesch, F | 1 |
| Cabellos, C; Force, E; Garrigós, C; Pachón-Ibañez, ME; Taberner, F | 1 |
| Adam, R; Michels, G; Müller, C; Nosseir, NS; Pfister, R; Wiesen, MH | 1 |
| Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
| Ghosh, C; Haldar, J; Konai, MM; Samaddar, S; Yarlagadda, V | 1 |
| Chambers, HF | 1 |
| Dilworth, TJ; Ibrahim, OM; Mercier, RC | 1 |
| Altay, MA; Baur, DA; Flores-Hidalgo, A; Ort, Y; Quereshy, FA | 1 |
| Alencar, LP; Bandeira, SP; Bandeira, TJ; Brilhante, RS; Castelo-Branco, DS; Cordeiro, RA; Monteiro, AJ; Moreira, JL; Oliveira, JS; Rocha, MF; Sidrim, JJ; Teixeira, CE | 1 |
| Maraki, S; Papadakis, IS | 1 |
| Barber, KE; Raut, A; Rybak, MJ; Smith, JR | 1 |
| Amer, AM; Badr, JM; Osman, KM; Saad, AS | 1 |
| Chrischilles, EA; Dawson, JD; Diekema, DJ; Goto, M; Herwaldt, LA; Jiang, L; McDanel, JS; Perencevich, EN; Schweizer, ML; Smith, TC | 1 |
| Beck, S; Gnewuch, C; Kees, MG; Moritz, S; Steinke, T | 1 |
| Abbo, LM; Rosa, R; Sfeir, M; Smith, L; Wawrzyniak, A | 1 |
| Chen, CS; Chen, JK; Chen, YS; Huang, TS; Lee, SS; Liu, YC; Sy, CL; Tsai, HC; Wann, SR; Wu, KS | 1 |
| Barnes, PD; Felder, KK; Marshall, LM; Vaz, LE | 1 |
| Raut, A; Rybak, MJ; Smith, JR; Yim, J | 1 |
| Israel, EN; Knoderer, CA; Nichols, KR; Thomas, CA | 1 |
| Du, J; Singh, H; Yi, TH | 2 |
| Chatfield, M; Cheng, AC; Davis, JS; Fowler, VG; Howden, BP; Lipman, J; Lye, D; Nelson, J; O'Sullivan, M; Paterson, DL; Robinson, JO; Tong, SY; Van Hal, S; Yahav, D | 1 |
| Leung, V; Romney, M; Wong, D; Wong, T | 2 |
| Agrinier, N; Charmillon, A; Dellamonica, J; Demoré, B; Kimmoun, A; Leone, M; Levy, B; Novy, E; Pulcini, C | 1 |
| Blumenthal, KG; Huang, M; Kuhlen, JL; Parker, RA; Shenoy, ES; Walensky, RP; Ware, WA | 1 |
| Arnold, C; Baddley, J; Bayer, A; Carugati, M; Chu, VH; Delahaye, F; Durante-Mangoni, E; Fernandez-Hidalgo, N; Garcia de la Maria, C; Hannan, MM; Kanafani, Z; Klein, JL; Miro, JM; Murdoch, D; Pericàs, JM; Petti, CA; Wray, D | 1 |
| Carroll, K; Romagnoli, M; Simner, PJ; Wang, F; Workneh, M | 1 |
| Kaysin, A; Viera, AJ | 1 |
| Chen, SY; Hsueh, PR; Huang, YT; Liao, CH; Tsai, HY | 1 |
| Cho, SY; Chung, DR; Ha, YE; Kang, CI; Ko, JH; Lee, NY; Park, GE; Peck, KR; Song, JH | 1 |
| Carugati, M; Chu, VH; Durante-Mangoni, E; Fowler, VG; Garcia-de-la-Mària, C; Kanafani, ZA; Marco, F; Messina, JA; Miró, JM; Moreno, A; Park, L; Pericàs, JM; Sharma-Kuinkel, BK; Tattevin, P; Wray, D | 1 |
| Ishii, M; Matsumoto, Y; Moriya, K; Okazaki, M; Sato, T; Sekimizu, K; Tabuchi, F; Tatsuno, K | 1 |
| Burgess, DS; Rutter, WC | 1 |
| Choi, JY; Go, J; Kim, HJ; Lee, K; Lee, KM; Park, IH; Shin, JS; Yoon, SS | 1 |
| Baroco, AL; Verma, R | 1 |
| Baud, D; Greub, G; Vouga, M | 1 |
| Brito, MAVP; Martins, LA; Mello, PL; Pinheiro, L; Ribeiro de Souza da Cunha, ML | 1 |
| Branch-Elliman, W; Gupta, K; Itani, KMF; O'Brien, WJ; Perencevich, E; Ripollone, JE; Schweizer, ML; Strymish, J | 1 |
| Bal, AM; David, MZ; Garau, J; Gottlieb, T; Gould, IM; Mazzei, T; Scaglione, F; Tattevin, P | 1 |
| Abramovitch, RB; Ackart, DF; Basaraba, RJ; Belardinelli, JM; Blackledge, MS; Jackson, M; Jeon, AB; Johnson, BK; Melander, C; Melander, RJ; Nguyen, TV; Obregón-Henao, A; Podell, BK | 1 |
| Beyda, ND; Bowers, DR; Casapao, AM; Dilworth, TJ; Jacobs, DM | 1 |
| Berti, AD; Chen, B; McCrone, S; Roch, M; Rosato, AE; Rose, WE; Zheng, X | 1 |
| Anderson, DJ; Fletcher, JM; Kram, BL; Kram, SJ; Sarubbi, CB | 1 |
| Rybak, MJ; Tran, N | 1 |
| Chen, XY; Hu, CY; Liu, Y; Xie, XF; Xu, RX; Zhou, X | 1 |
| Aguiar Cordeiro, R; Carneiro Câmara, LM; Colares de Andrade, AR; Costa Sidrim, JJ; de Alencar, LP; de Jesus Evangelista, AJ; de Oliveira, JS; Gadelha Rocha, MF; Leite Mendes, PB; Nogueira Brilhante, RS; Sales, JA; Serpa, R; Silva Franco, JD; Souza Collares Maia Castelo-Branco, D | 1 |
| Foster, TJ | 1 |
| Beyda, ND; Bowers, DR; Casapao, AM; Dilworth, TJ; Ibrahim, OM; Jacobs, DM; Mercier, RC | 1 |
| Aoki, K; Fujisaki, M; Hamada, M; Ishii, Y; Kajiwara, C; Kato, K; Kimura, S; Murakami, H; Ono, D; Sasaki, M; Sato, A; Sonoda, S; Tateda, K; Tojo, H; Yamaguchi, T | 1 |
| Blackledge, MS; Cutrona, N; Gillard, K; Miller, HB; Seemann, M; Ulrich, R | 1 |
| Chang, MJ; Han, E; Kang, S; Park, J; Park, MS; Yu, YM | 1 |
| Barreto, EF; Rule, AD; Schreier, DJ | 1 |
| Abdul-Mutakabbir, JC; Alosaimy, S; Bhatia, S; Davis, SL; Jorgensen, SCJ; Lagnf, AM; Mynatt, RP; Rybak, MJ; Sabagha, N; Trinh, TD; Zasowski, EJ | 1 |
| Leszczynski, P; Mlynarczyk, A; Mlynarczyk, G; Sawicka-Grzelak, A; Sokol-Leszczynska, B | 1 |
| Beall, G; Cotta, MO; Roberts, JA; Williams, P | 1 |
| Churilov, L; Devchand, M; Moran, RL; Trubiano, JA; Warrillow, S | 1 |
| Cobian, J; Hall, B; Miller, J; Wilson, K | 1 |
| Gandhi, TN; Malani, PN | 1 |
| Anagnostou, NA; Andresen, DN; Archuleta, S; Bak, N; Cass, A; Chatfield, MD; Cheng, AC; Davies, J; Davis, JS; Dotel, R; Ferguson, PE; Foo, H; Fowler, VG; Ghosh, N; Gray, TJ; Guy, SD; Holmes, NE; Howden, BP; Johnson, SA; Kalimuddin, S; Lye, DC; McBride, S; McKew, GL; Meagher, N; Nelson, J; O'Sullivan, MVN; Paterson, DL; Paul, M; Price, DJ; Ralph, AP; Roberts, MA; Robinson, JO; Rogers, BA; Runnegar, N; Smith, S; Sud, A; Tong, SYC; Tramontana, AR; van Hal, SJ; Walls, GB; Warner, MS; Yahav, D; Young, BE | 1 |
| Bellos, I; Karageorgiou, V; Pergialiotis, V; Perrea, DN | 1 |
| Burgess, DR; Burgess, DS; Wilsey, HA | 1 |
| Beatty, KE | 1 |
| Giuliano, C; Jongekrijg, A; Kale-Pradhan, PB; Rybak, MJ | 1 |
| Cusumano, JA; Huttner, A; Klinker, KP; LaPlante, KL; Luther, MK; Roberts, JA | 1 |
| Atalla, E; Mylonakis, E | 1 |
| Kebriaei, R; Nguyen, L; Rice, SA; Rybak, MJ; Sheikh, Z; Singh, NB; Stamper, KC | 1 |
| Blyth, CC; Bowen, AC; Campbell, AJ; McMullan, BJ; McNeil, JC; Montgomery, CP; Tong, SYC | 1 |
| Deng, C; Hu, Y; Liao, L; Liu, L; Wang, C; Wang, Z; Ye, C | 1 |
| Deng, C; Hu, Y; Liao, L; Sun, L; Wang, C; Wang, Z; Ye, C | 1 |
| Blanch Sancho, JJ; García Aragonés, L; Martínez Alfaro, E; Mateos Rodriguez, F; Segura Luque, JC; Solís García Del Pozo, J | 1 |
| Booncharoen, S; Chaiyapoke, C; Chanawong, A; Lulitanond, A; Srisrattakarn, A; Tavichakorntrakool, R; Tippayawat, P; Wongthong, S | 1 |
| Wang, JL; Xu, WH; Yi, YH; Yin, WJ | 1 |
| Crawford, S; Cuenca, J; Ghosh, N; Newton, P; Reynolds, G | 1 |
| Cutrell, JB; Sanders, JM | 1 |
| Amoah, J; Chiotos, K; Cosgrove, SE; Klein, EY; Tamma, PD | 1 |
| Abdul-Aziz, MH; Brady, K; Cotta, MO; Roberts, JA | 1 |
| Abdulla, A; de Winter, BCM; Endeman, H; Ewoldt, TMJ; Hunfeld, NGM; Koch, BCP; Muller, AE | 1 |
| Lizza, BD; Micek, ST; Raush, N | 1 |
| Arias, CA; Axell-House, D; Khan, A; Miller, WR; Munita, JM | 1 |
| Ahn, JY; Kim, HR; Kim, YC; La, YJ; Oh, DH | 1 |
| Choi, U; Lee, CR; Lee, HB; Lee, JW; Park, SH; Ryu, SH | 1 |
| Abruzzi, J; Kopczynski, A; Montes, THM; Nedel, WL; Portela, LV; Rodolphi, MS; Strogulski, NR | 1 |
| Alosaimy, S; Amaya, L; Biagi, M; Chandler, E; Cubillos, A; Davis, SL; Finch, N; Hobbs, ALV; Holger, D; Jorgensen, SCJ; Kufel, WD; Kunz Coyne, AJ; Lagnf, AM; Li, D; Molina, KC; Moore, WJ; Morrisette, T; Mubarez, M; Patch, M; Polisetty, RS; Rebold, N; Rico, M; Rybak, MJ; Sakoulas, G; Simon, SP; Smith, IMK; Tran, NN; Truong, J; Venugopalan, V; Veve, MP; Witucki, P; Wrin, J; Yost, C | 1 |
| Hu, X; Liang, Y; Lou, J; Luo, Y; Meng, Q; Yin, J; Yu, Z; Zhu, T; Zhu, Y | 1 |
| Das, AK; Dudeja, M; Kohli, S; Ray, P | 1 |
| Cass, A; Davies, J; Davis, JS; Johnson, SA; Legg, A; Meagher, N; Roberts, JA; Roberts, MA; Scheetz, MH; Tong, SYC | 1 |
| Antcliffe, DB; Arkell, P; Gilchrist, M; Holmes, A; Rawson, TM; Watkins, K; Wilson, M; Wilson, R | 1 |
| Chang, SC; Chen, YC; Chuang, YC; Huang, SH; Lin, CY; Wang, JT; Yang, JL | 1 |
| Daneman, N; Lam, PW; Leis, JA | 1 |
| Bielawski, JP; Dunn, KA; Kulkarni, K; Langille, MGI; MacDonald, J; MacDonald, T; Van Limbergen, JE | 1 |
| Abdul Aziz, MH; Alshaer, MH; Ausman, SE; Barreto, EF; Boehmer, KR; Chitre, PN; Jannetto, PJ; Mara, KC; Moreland-Head, LN; Pine, KH; Rivera, CG; Roberts, JA; Rule, AD; Scheetz, MH; Shepel, KK | 1 |
35 review(s) available for vancomycin and beta-lactams
| Article | Year |
|---|---|
[Evaluation of hematologic side effects of anti-infective therapy: agranulocytosis caused by beta-lactam antibiotics, vancomycin and amodiaquine].
Topics: Agranulocytosis; Amodiaquine; Animals; Anti-Bacterial Agents; beta-Lactams; Humans; Neutropenia; Vancomycin | 1991 |
Use of anti-infective agents during lactation: Part 1--Beta-lactam antibiotics, vancomycin, quinupristin-dalfopristin, and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Drug Therapy, Combination; Female; Humans; Lactation; Linezolid; Milk, Human; Mothers; Oxazolidinones; Vancomycin; Virginiamycin | 2000 |
Hypersensitivity reactions to non-beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Antiviral Agents; beta-Lactams; Drug Hypersensitivity; Fluoroquinolones; Humans; Hypersensitivity, Immediate; Incidence; Macrolides; Sulfonamides; Tetracyclines; Vancomycin | 2003 |
[Antibiotics and overweight].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Body Weight; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Obesity; Penicillins; Quinolones; Vancomycin | 2005 |
Antibiotic resistance in Staphylococcus aureus and its relevance in therapy.
Topics: Acetamides; Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Bacterial; Glycopeptides; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Vaccination; Vaccines, DNA; Vancomycin; Vancomycin Resistance | 2005 |
MRSA--the tip of the iceberg.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Gram-Positive Bacteria; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Ciprofloxacin; Critical Care; Drug Administration Schedule; Drug Monitoring; Humans; Sepsis; Vancomycin | 2006 |
The implications of enterococci for the intensive care unit.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Infection Control; Intensive Care Units; Peritonitis; Risk Factors; Vancomycin | 2007 |
[BIVR].
Topics: Animals; Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactams; Drug Interactions; Drug Therapy, Combination; Humans; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Female; Humans; Male; Teicoplanin; Vancomycin | 2009 |
Some current issues in the pharmacokinetics/pharmacodynamics of antimicrobials in intensive care.
Topics: Anti-Infective Agents; beta-Lactams; Critical Care; Drug Administration Schedule; Drug Resistance, Microbial; Humans; Vancomycin | 2010 |
Dress syndrome and acute tubulointerstitial nephritis after treatment with vancomycin and beta-lactams. Case report and literature review.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Drug Hypersensitivity; Female; Humans; Nephritis, Interstitial; Syndrome; Vancomycin | 2012 |
Anti-infectious agents against MRSA.
Topics: Acetylcysteine; Alkyl and Aryl Transferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cell Wall; Diterpenes; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycotoxins; Organothiophosphorus Compounds; Peptidoglycan; Spiro Compounds; Teichoic Acids; Vancomycin; Virulence Factors; Xanthophylls | 2012 |
[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Daptomycin; Disease Models, Animal; Fluoroquinolones; Fosfomycin; Guidelines as Topic; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2013 |
The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2013 |
Vancomycin-resistant enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2013 |
[Therapeutic Drug Monitoring of antiinfectives in intensive care medicine].
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Biological Availability; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Fluoroquinolones; Guideline Adherence; Humans; Intensive Care Units; Linezolid; Metabolic Clearance Rate; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Shock, Septic; Teicoplanin; Vancomycin | 2014 |
Rothia mucilaginosa pneumonia: a literature review.
Topics: Anti-Bacterial Agents; beta-Lactams; Hematologic Neoplasms; Humans; Immunocompetence; Immunocompromised Host; Lung; Male; Micrococcaceae; Middle Aged; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Radiography; Vancomycin | 2015 |
Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen.
Topics: Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Multicenter Studies as Topic; Staphylococcal Infections; Vancomycin | 2017 |
Acute kidney injury associated with concomitant vancomycin and piperacillin/tazobactam administration: a systematic review and meta-analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2018 |
Can β-Lactam Antibiotics Be Resurrected to Combat MRSA?
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Synergism; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2019 |
Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; beta-Lactams; Child; Cohort Studies; Drug Therapy, Combination; Humans; Incidence; Intensive Care Units; Network Meta-Analysis; Pseudomonas Infections; Vancomycin | 2020 |
Focusing the Lens on the CAMERA Concepts: Early Combination β-Lactam and Vancomycin Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2020 |
Fluorescent probes for investigating peptidoglycan biosynthesis in mycobacteria.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biosynthetic Pathways; Fluorescent Dyes; Humans; Models, Molecular; Mycobacterium tuberculosis; Optical Imaging; Peptides; Peptidoglycan; Peptidyl Transferases; Tuberculosis; Vancomycin | 2020 |
Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysis.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Randomized Controlled Trials as Topic; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2020 |
Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Topics: Aged; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Bacterial; Humans; Obesity; Precision Medicine; Vancomycin | 2020 |
Clinical Management of
Topics: Adolescent; Age Factors; Algorithms; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Catheter-Related Infections; Cephalosporins; Child; Child, Preschool; Delphi Technique; Drug Administration Schedule; Echocardiography; Endocarditis, Bacterial; Glycopeptides; Humans; Incidence; Infant; Infant, Newborn; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Penicillins; Randomized Controlled Trials as Topic; Referral and Consultation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
Adjuvant β-Lactam Therapy Combined with Vancomycin or Daptomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2020 |
Systematic review and meta-analysis of the efficacy and safety of vancomycin combined with β-lactam antibiotics in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2020 |
What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cloxacillin; Daptomycin; Floxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2022 |
Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Drug Therapy, Combination; Humans; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Randomized Controlled Trials as Topic; Staphylococcal Infections; Vancomycin | 2021 |
Therapeutic Drug Monitoring of Antibiotics: Defining the Therapeutic Range.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Monitoring; Humans; Vancomycin | 2022 |
Therapeutic Drug Monitoring of Antibiotics in Critically Ill Patients: Current Practice and Future Perspectives With a Focus on Clinical Outcome.
Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Drug Monitoring; Humans; Vancomycin | 2022 |
Antimicrobial Susceptibility Testing for Enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Daptomycin; Enterococcus; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Tetracycline; Vancomycin | 2022 |
Application of therapeutic drug monitoring to the treatment of bacterial central nervous system infection: a scoping review.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Central Nervous System Infections; Drug Monitoring; Humans; Vancomycin | 2022 |
6 trial(s) available for vancomycin and beta-lactams
| Article | Year |
|---|---|
Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Cohort Studies; Female; Hospitals, University; Humans; Korea; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Infectious Disease Medicine; Long-Term Care; Nitrofurantoin; Nursing Homes; Referral and Consultation; Regression Analysis; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2012 |
Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Diabetic Foot; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Female; Humans; Male; Middle Aged; Minocycline; Nausea; Osteomyelitis; Tigecycline; Treatment Outcome; Vancomycin; Vomiting; Young Adult | 2014 |
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
Topics: Anti-Bacterial Agents; Australia; beta-Lactams; Cefazolin; Clinical Protocols; Cloxacillin; Daptomycin; Drug Therapy, Combination; Floxacillin; Humans; Israel; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; New Zealand; Research Design; Singapore; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Floxacillin; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Drug-Related Side Effects and Adverse Reactions; Humans; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2023 |
141 other study(ies) available for vancomycin and beta-lactams
| Article | Year |
|---|---|
The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Enterococcus; Humans; Vancomycin | 1991 |
Influence of beta-lactam antibiotics, fosfomycin and vancomycin on the adherence (hemagglutination) of Escherichia coli-containing different adhesins.
Topics: Adhesiveness; Anti-Bacterial Agents; beta-Lactams; Escherichia coli; Fimbriae, Bacterial; Fosfomycin; Hemagglutination Tests; Vancomycin | 1985 |
Antibiotic resistance pattern of Flavobacterium meningosepticum.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Chloramphenicol; Clindamycin; Drug Resistance, Microbial; Erythromycin; Flavobacterium; Humans; Infant, Newborn; Isoelectric Focusing; Rifampin; Tetracycline; Vancomycin | 1986 |
Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Carrier State; Child; Drug Combinations; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Rifampin; Streptococcus pneumoniae; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1984 |
Variable tolerance of a clinical isolate of Staphylococcus epidermidis from an infected hydrocephalus shunt for several beta-lactam antibiotics, vancomycin and fosfomycin.
Topics: Anti-Bacterial Agents; beta-Lactams; Cerebrospinal Fluid Shunts; Drug Resistance, Microbial; Fosfomycin; Humans; Hydrocephalus; Infant; Microbial Sensitivity Tests; Staphylococcus; Vancomycin | 1981 |
[Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus].
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1993 |
Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinations.
Topics: Adult; Anti-Bacterial Agents; Base Sequence; beta-Lactams; DNA Probes; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Humans; Immunoblotting; Microbial Sensitivity Tests; Molecular Sequence Data; Novobiocin; Penicillins; Phenotype; Vancomycin | 1993 |
Lack of correlation between in vitro and in vivo studies of combinations of rifampin plus vancomycin or beta-lactam antibiotics against Streptococcus pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; beta-Lactams; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Rabbits; Rifampin; Streptococcus pneumoniae; Vancomycin | 1996 |
In-vitro study of the synergy between beta-lactam antibiotics and glycopeptides against enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Imipenem; Microbial Sensitivity Tests; Piperacillin; Teicoplanin; Vancomycin | 1997 |
Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus; Vancomycin | 1999 |
[Septic arthritis by Streptococcus equisimilis in a patient allergic to beta-lactam antibiotics and aminoglycosides].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Arthritis, Infectious; beta-Lactams; Drug Hypersensitivity; Female; Humans; Streptococcal Infections; Vancomycin | 1999 |
In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Netilmicin; Staphylococcus aureus; Vancomycin | 2000 |
Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin.
Topics: Anti-Bacterial Agents; beta-Lactams; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Drug Therapy, Combination; Microbial Sensitivity Tests; Peptidoglycan; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2001 |
Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; beta-Lactams; Enterobacteriaceae; Enterococcus faecalis; Fluoroquinolones; Indoles; Kinetics; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcus aureus; Streptococcus; Vancomycin | 2001 |
Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Disease Models, Animal; Ertapenem; Lactams; Meningitis, Pneumococcal; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Vancomycin | 2003 |
[Epidemiological investigation of "beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)"].
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Epidemiology; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2003 |
[Epidemiological investigation of MRSA with antagonistic effects of beta-lactam antibiotic and vancomycin].
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Antagonism; Humans; Japan; Methicillin Resistance; Retrospective Studies; Staphylococcus aureus; Vancomycin | 2003 |
Method of detecting beta-lactam antibiotic induced vancomycin resistant MRSA (BIVR).
Topics: beta-Lactams; Drug Antagonism; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2004 |
In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
Topics: Acetamides; Anti-Bacterial Agents; Bacillus anthracis; beta-Lactams; Chloramphenicol; Clindamycin; Fluoroquinolones; Linezolid; Macrolides; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Tetracyclines; Vancomycin; Virginiamycin | 2004 |
False synergy between vancomycin and beta-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Synergism; False Positive Reactions; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Teicoplanin; Vancomycin | 2004 |
[Therapeutic effects of vancomycin, teicoplanin, and ceftizoxime alone and in combination against murine systemic infection in mice caused by "beta-lactam antibiotic induced vancomycin-resistant MRSA"].
Topics: Animals; beta-Lactams; Drug Therapy, Combination; Methicillin Resistance; Mice; Mice, Inbred ICR; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Vancomycin Resistance | 2004 |
The glycopeptide vancomycin does not enhance toll-like receptor 2 (TLR2) activation by Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cell Wall; Cephalosporins; Genes, Reporter; HeLa Cells; Humans; Interleukin-8; Lactams; Lipopolysaccharide Receptors; Luciferases; Membrane Glycoproteins; Microbial Sensitivity Tests; Plasmids; Receptors, Cell Surface; Streptococcus pneumoniae; Toll-Like Receptor 2; Toll-Like Receptors; Transfection; Vancomycin | 2004 |
[Epidemiology and clinical effect against "beta-lactam antibiotic induced vancoymcin-resistant MRSA (BIVR)"].
Topics: beta-Lactams; Drug Antagonism; Methicillin Resistance; Staphylococcus aureus; Teicoplanin; Vancomycin; Vancomycin Resistance | 2004 |
[Epidemiological investigation of beta-lactam antibiotic induced vancomycin-resistant MRSA from clinical isolated MRSA--comparison of detection rate of BIVR with or without CZX].
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftizoxime; Drug Resistance, Multiple, Bacterial; Humans; Methicillin Resistance; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2004 |
Antimicrobial resistance of enterococci in Turkey.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Body Fluids; Catheterization; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Teicoplanin; Turkey; Urine; Vancomycin; Wounds and Injuries | 2005 |
MRSA in the community.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Community-Acquired Infections; Enterotoxins; Female; Humans; Methicillin Resistance; Risk Factors; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Vancomycin | 2005 |
Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Administration Schedule; Female; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome; Vancomycin | 2006 |
[Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)].
Topics: Animals; beta-Lactams; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2006 |
In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cephalothin; Dicloxacillin; Drug Synergism; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin | 2006 |
Endocarditis caused by Gemella morbillorum resistant to beta-lactams and aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Staphylococcaceae; Vancomycin | 2006 |
Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Critical Pathways; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Preoperative Care; Skin Tests; Treatment Outcome; Vancomycin | 2006 |
[Do we have adequate antimicrobials against methicillin-resistant Staphylococcus aureus?].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Cross Infection; Drug Design; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Europe; Humans; Methicillin Resistance; Penicillin-Binding Proteins; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 2006 |
Treatment of Staphylococcus aureus prosthetic valve endocarditis.
Topics: Aminoglycosides; beta-Lactams; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Male; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
Ertapenem resistance of Escherichia coli.
Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluconazole; Gentamicins; Humans; Imipenem; Immunocompromised Host; Middle Aged; Vancomycin | 2007 |
Insufficient therapy for nosocomial meningitis negatively affects survival, sequellae and has social consequences.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Retrospective Studies; Treatment Failure; Vancomycin | 2007 |
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Rapid depletion of free vancomycin in medium in the presence of beta-lactam antibiotics and growth restoration in Staphylococcus aureus strains with beta-lactam-induced vancomycin resistance.
Topics: beta-Lactams; Drug Antagonism; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Microanalysis of beta-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefotaxime; Ceftriaxone; Chromatography, High Pressure Liquid; Humans; Infant, Newborn; Meropenem; Tandem Mass Spectrometry; Thienamycins; Vancomycin | 2009 |
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
Topics: Anti-Bacterial Agents; beta-Lactams; Blotting, Northern; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Imipenem; Microbial Sensitivity Tests; Mutation; Sequence Analysis, DNA; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
[Evaluation of rapid antimicrobial susceptibility test for Staphylococcus aureus by chemiluminescent assay and its application for screening of beta-lactam antibiotic induced vancomycin-resistant MRSA].
Topics: beta-Lactams; Luminescent Measurements; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Teicoplanin; Vancomycin; Vancomycin Resistance | 2008 |
Differential expression of ccrA in methicillin-resistant Staphylococcus aureus strains carrying staphylococcal cassette chromosome mec type II and IVa elements.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Galactosidase; beta-Lactamases; beta-Lactams; Gene Expression Regulation, Bacterial; Methicillin-Resistant Staphylococcus aureus; Nitrophenylgalactosides; Reverse Transcriptase Polymerase Chain Reaction; Vancomycin | 2009 |
Evaluation of antibiotic therapy following valve replacement for native valve endocarditis.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Retrospective Studies; Rifampin; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance | 2009 |
Laboratory and clinical characteristics of Staphylococcus lugdunensis prosthetic joint infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthritis; beta-Lactamases; beta-Lactams; Cohort Studies; Female; Genes, Bacterial; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Minnesota; Prevalence; Prosthesis-Related Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Treatment Outcome; Vancomycin | 2010 |
Induction of beta-lactamase production in Aeromonas hydrophila is responsive to beta-lactam-mediated changes in peptidoglycan composition.
Topics: Aeromonas hydrophila; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Mutagenesis, Insertional; Peptidoglycan; Vancomycin | 2010 |
Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Colistin; Conjugation, Genetic; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Escherichia coli; Escherichia coli Infections; Gastrointestinal Tract; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Metronidazole; Plasmids; Vancomycin | 2010 |
Serotypes and susceptibilities of paediatric clinical isolates of Streptococcus pneumoniae in Crete, Greece, before and after the heptavalent pneumococcal conjugate vaccine.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Chloramphenicol; Clindamycin; Greece; Heptavalent Pneumococcal Conjugate Vaccine; History, 21st Century; Humans; Immunization Programs; Macrolides; Microbial Sensitivity Tests; Pneumococcal Infections; Pneumococcal Vaccines; Quinolones; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vaccines, Conjugate; Vancomycin | 2010 |
Acute bacterial meningitis.
Topics: Acute Disease; Bacterial Vaccines; beta-Lactams; Child; Combined Modality Therapy; Drug Resistance, Bacterial; Humans; Infant; Meningitis, Bacterial; Vancomycin | 2010 |
Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Enterococcus; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Staphylococcus aureus; Taiwan; Teicoplanin; Vancomycin | 2011 |
Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?
Topics: Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; beta-Lactams; Cross Infection; Drug Combinations; Drug Evaluation; Female; Humans; Logistic Models; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2011 |
Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain.
Topics: Adult; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Clostridioides difficile; Clostridium Infections; Comorbidity; Humans; Male; Ohio; Treatment Outcome; Vancomycin | 2011 |
Factors predicting mortality in invasive pneumococcal disease in adults in Alberta.
Topics: Adolescent; Adult; Alberta; Anti-Bacterial Agents; beta-Lactams; Cognition Disorders; Comorbidity; Drug Therapy, Combination; Female; Humans; Lung; Macrolides; Male; Multivariate Analysis; Pneumococcal Infections; Renal Insufficiency; Respiratory Distress Syndrome; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome; Vancomycin; Young Adult | 2011 |
Variability in pediatric infectious disease consultants' recommendations for management of community-acquired pneumonia.
Topics: Anti-Bacterial Agents; beta-Lactams; Clindamycin; Community-Acquired Infections; Data Collection; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Vancomycin | 2011 |
Diagnosis and management of community-acquired pneumonia in adults.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Community-Acquired Infections; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Humans; Influenza Vaccines; Linezolid; Macrolides; Oxazolidinones; Pneumococcal Vaccines; Pneumonia, Bacterial; Practice Guidelines as Topic; Risk Factors; Treatment Outcome; United States; Vancomycin | 2011 |
High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Glycopeptides; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2011 |
Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cross-Sectional Studies; Female; Fluoroquinolones; Genes, Regulator; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; New York; Risk Factors; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2011 |
A PBP 2 mutant devoid of the transpeptidase domain abolishes spermine-β-lactam synergy in Staphylococcus aureus Mu50.
Topics: Anti-Bacterial Agents; beta-Lactams; Cell Wall; Drug Combinations; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Hydrogen-Ion Concentration; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Plasmids; Protein Structure, Tertiary; Spermine; Staphylococcal Infections; Transcriptome; Transformation, Bacterial; Vancomycin | 2012 |
Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
Topics: Adult; Aged; Algeria; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Fosfomycin; Gentamicins; Hospitals, University; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Rifampin; Staphylococcal Infections; Surgical Wound Infection; Vancomycin; Vancomycin Resistance | 2011 |
Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Models, Biological; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2012 |
Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; United States; Vancomycin; Vancomycin Resistance | 2012 |
Reduced expression of PBP-2A by neonatal mecA-positive coagulase-negative staphylococci (CoNS) blood isolates: β-lactams are useful first-line agents for the treatment of neonatal CoNS sepsis, restricting the use of vancomycin.
Topics: Anti-Bacterial Agents; beta-Lactams; Coagulase; DNA, Bacterial; Gene Expression; Humans; Infant, Newborn; Methicillin Resistance; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sepsis; Staphylococcus; Vancomycin | 2012 |
Low level ß-lactamase production in methicillin-resistant staphylococcus aureus strains with ß-lactam antibiotics-induced vancomycin resistance.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA, Bacterial; Gene Expression Regulation, Bacterial; Methicillin-Resistant Staphylococcus aureus; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2012 |
Comparison of the WST-8 colorimetric method and the CLSI broth microdilution method for susceptibility testing against drug-resistant bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Colorimetry; Culture Media; Enterococcus faecalis; Haemophilus influenzae; Indicator Dilution Techniques; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Vancomycin; Vancomycin Resistance | 2012 |
Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive staphylococcus aureus surgical site infections: report from Australian Surveillance Data (VICNISS).
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Australia; beta-Lactams; Humans; Methicillin; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 2012 |
National survey on continuous and extended infusions of antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Communicable Diseases; Drug Administration Schedule; Health Care Surveys; Humans; Infusions, Intravenous; Pharmacy Service, Hospital; Societies, Pharmaceutical; Time Factors; United States; Vancomycin | 2012 |
A survey of beta-lactam antibiotics and vancomycin dosing strategies in intensive care units and general wards in Belgian hospitals.
Topics: Anti-Bacterial Agents; Belgium; beta-Lactams; Health Care Surveys; Hospitals; Humans; Intensive Care Units; Patients' Rooms; Surveys and Questionnaires; Vancomycin | 2013 |
β-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2014 |
Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss transplant cohort study.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; beta-Lactams; Cohort Studies; Enterococcus; Enterococcus faecium; Female; Graft Rejection; Gram-Positive Bacterial Infections; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Lung Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Organ Transplantation; Penicillin Resistance; Penicillins; Prospective Studies; Recombinant Fusion Proteins; Risk Factors; Switzerland; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2014 |
Common use of the empirical combination of vancomycin and a β-lactam for staphylococcal bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2014 |
D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Amino Acids; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Biofilms; Clindamycin; Drug Synergism; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Surface-Active Agents; Vancomycin; Wounds and Injuries | 2014 |
Determination of free vancomycin, ceftriaxone, cefazolin and ertapenem in plasma by ultrafiltration: impact of experimental conditions.
Topics: beta-Lactams; Cefazolin; Ceftriaxone; Drug Stability; Ertapenem; Humans; Protein Binding; Ultrafiltration; Vancomycin | 2014 |
Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Ceftriaxone; Drug Resistance, Bacterial; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2014 |
Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
Topics: Acetamides; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Glycopeptides; Linezolid; Meningitis, Bacterial; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Random Allocation; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2014 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
Membrane active phenylalanine conjugated lipophilic norspermidine derivatives with selective antibacterial activity.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Design; Drug Resistance, Bacterial; Enterococcus faecium; Humans; Kinetics; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Micelles; Microbial Sensitivity Tests; Molecular Conformation; Phenylalanine; Plasma; Serum; Spermidine; Tetrazolium Salts; Thiazoles; Vancomycin | 2014 |
Probability of eradication using vancomycin alone or in combination for methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Vancomycin | 2014 |
Reply to "Probability of eradication using vancomycin alone or in combination for methicillin-resistant Staphylococcus aureus bacteremia".
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Vancomycin | 2014 |
Chronic osteomyelitis of the mandible: diagnosis and management--an institution's experience over 7 years.
Topics: Administration, Intravenous; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Chronic Disease; Clindamycin; Doxycycline; Ertapenem; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Male; Mandibular Diseases; Mandibular Fractures; Middle Aged; Osteomyelitis; Osteosclerosis; Retrospective Studies; Sulbactam; Treatment Outcome; Vancomycin; Young Adult | 2015 |
β-Lactam antibiotics and vancomycin inhibit the growth of planktonic and biofilm Candida spp.: an additional benefit of antibiotic-lock therapy?
Topics: Anti-Bacterial Agents; beta-Lactams; Biofilms; Candida; Catheter-Related Infections; Humans; Microbial Sensitivity Tests; Microbial Viability; Vancomycin | 2015 |
β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Ertapenem; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2015 |
Prevalence and antimicrobial resistance profile of Staphylococcus species in chicken and beef raw meat in Egypt.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cattle; Chickens; Drug Resistance, Multiple, Bacterial; Egypt; Food Contamination; Food Microbiology; Meat; Microbial Sensitivity Tests; Penicillins; Red Meat; Staphylococcus; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Vancomycin; Vancomycin Resistance | 2015 |
Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin | 2015 |
Estimation of creatinine clearance using plasma creatinine or cystatin C: a secondary analysis of two pharmacokinetic studies in surgical ICU patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Creatinine; Critical Care; Cystatin C; Female; Glomerular Filtration Rate; Humans; Kidney Function Tests; Male; Middle Aged; ROC Curve; Vancomycin; Young Adult | 2015 |
Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cross Infection; Echocardiography; Female; Florida; Hospital Mortality; Hospitals, Teaching; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2016 |
Synergy of β-Lactams with Vancomycin against Methicillin-Resistant Staphylococcus aureus: Correlation of Disk Diffusion and Checkerboard Methods.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin | 2016 |
Risk Factors for Complications during Outpatient Parenteral Antimicrobial Therapy for Adult Orthopedic and Neurosurgical Infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Bone Diseases; Cohort Studies; Female; Humans; Injections, Intravenous; Male; Middle Aged; Nervous System Diseases; Outpatient Clinics, Hospital; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2016 |
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2016 |
Optimizing Guideline-Recommended Antibiotic Doses for Pediatric Infective Endocarditis.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Child; Endocarditis, Bacterial; Humans; Practice Guidelines as Topic; United States; Vancomycin | 2016 |
Biosynthesis of silver nanoparticles using Aeromonas sp. THG-FG1.2 and its antibacterial activity against pathogenic microbes.
Topics: Aeromonas; Anti-Bacterial Agents; Antifungal Agents; beta-Lactams; Candida; Disk Diffusion Antimicrobial Tests; Drug Synergism; Gram-Negative Bacteria; Gram-Positive Bacteria; Green Chemistry Technology; Macrolides; Metal Nanoparticles; Particle Size; Silver Nitrate; Vancomycin | 2017 |
Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactams; Female; Humans; Male; Methicillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2016 |
The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France.
Topics: Adult; Aged; Anti-Bacterial Agents; Attitude of Health Personnel; beta-Lactams; Critical Illness; Cross-Sectional Studies; Drug Monitoring; Drug Utilization; Female; France; Humans; Male; Middle Aged; Professional Competence; Surveys and Questionnaires; Vancomycin | 2016 |
Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Canada; Cohort Studies; Female; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2016 |
The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Hypersensitivity; Female; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Retrospective Studies; Skin Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2016 |
Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis.
Topics: Aged; beta-Lactams; Coagulase; Cohort Studies; Endocarditis, Bacterial; Female; Hospital Mortality; Humans; Male; Methicillin; Middle Aged; Prospective Studies; Staphylococcal Infections; Staphylococcus; Vancomycin | 2016 |
Bypass graft infection and bacteremia caused by Anaerostipes caccae: First report of human infection caused by a recently described gut anaerobe.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anastomosis, Surgical; Anti-Bacterial Agents; beta-Lactams; Blood Culture; Clostridiales; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surgical Wound Infection; Vancomycin | 2016 |
Community-Acquired Pneumonia in Adults: Diagnosis and Management.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Community-Acquired Infections; Doxycycline; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Macrolides; Male; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2016 |
Comparison of in vitro synergy of various β-lactams with vancomycin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin | 2017 |
Empirical combination of a β-lactam to vancomycin may not improve outcomes of methicillin-susceptible Staphylococcus aureus bacteremia, compared to vancomycin monotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Retrospective Studies; Staphylococcal Infections; Survival Analysis; Tertiary Care Centers; Treatment Outcome; Vancomycin; Young Adult | 2017 |
Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the Internationa
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Endocarditis, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Multiplex Polymerase Chain Reaction; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Treatment Outcome; Vancomycin; Virulence Factors | 2017 |
Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Bombyx; Ceftriaxone; Disease Models, Animal; Drug Synergism; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2017 |
Kinneretia THG-SQI4 mediated biosynthesis of silver nanoparticles and its antimicrobial efficacy.
Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Lactams; Candida; Comamonadaceae; Disk Diffusion Antimicrobial Tests; Drug Synergism; Gram-Negative Bacteria; Gram-Positive Bacteria; Green Chemistry Technology; Macrolides; Metal Nanoparticles; Particle Size; Silver Nitrate; Vancomycin | 2017 |
Acute Kidney Injury in Patients Treated with IV Beta-Lactam/Beta-Lactamase Inhibitor Combinations.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Vancomycin | 2017 |
A Genetic Screen Reveals Novel Targets to Render
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Caenorhabditis elegans; Cell Wall; Disease Models, Animal; DNA Transposable Elements; Gene Knockout Techniques; Genetic Complementation Test; Genetic Testing; Mice, Inbred C57BL; Microbial Viability; Muramidase; Mutagenesis, Insertional; Pseudomonas aeruginosa; Pseudomonas Infections; Vancomycin; Virulence | 2017 |
Topics: Aged; Ampicillin; Bacteremia; beta-Lactams; Clostridioides difficile; Diagnosis, Differential; Enterococcus faecalis; Gram-Positive Bacterial Infections; Hepatitis A; Humans; Infusions, Intravenous; Male; Vancomycin | 2017 |
Simkania negevensis, an Example of the Diversity of the Antimicrobial Susceptibility Pattern among Chlamydiales.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cell Line; Chlamydiaceae Infections; Chlamydiales; Chlorocebus aethiops; Clindamycin; Macrolides; Microbial Sensitivity Tests; Quinolones; Rifampin; Vancomycin; Vero Cells | 2017 |
Short communication: β-Lactam resistance and vancomycin heteroresistance in Staphylococcus spp. isolated from bovine subclinical mastitis.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cattle; Female; Mastitis, Bovine; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; Vancomycin; Vancomycin Resistance | 2017 |
Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Clostridioides difficile; Clostridium Infections; Cohort Studies; Drug Combinations; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Surgical Wound Infection; United States; United States Department of Veterans Affairs; Vancomycin | 2017 |
2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability.
Topics: Anti-Infective Agents; beta-Lactamases; beta-Lactams; Carbenicillin; Cell Membrane Permeability; Coloring Agents; Imidazoles; Lipids; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acids; Penicillin V; Sodium Dodecyl Sulfate; Staining and Labeling; Transcription, Genetic; Vancomycin | 2017 |
Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2017 |
Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2018 |
Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2019 |
β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA.
Topics: beta-Lactams; Cefazolin; Cefepime; Ceftaroline; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin | 2018 |
β-lactam antibiotics & vancomycin increase the growth & virulence of Candida spp.
Topics: Animals; Antifungal Agents; beta-Lactams; Caenorhabditis elegans; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Vancomycin; Virulence | 2018 |
Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Observational Studies as Topic; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2019 |
Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Synergism; Drug Therapy, Combination; Humans; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2019 |
From Antihistamine to Anti-infective: Loratadine Inhibition of Regulatory PASTA Kinases in Staphylococci Reduces Biofilm Formation and Potentiates β-Lactam Antibiotics and Vancomycin in Resistant Strains of
Topics: Anti-Bacterial Agents; beta-Lactams; Biofilms; Drug Resistance, Bacterial; Loratadine; Microbial Sensitivity Tests; Molecular Docking Simulation; Phosphotransferases; Protein Serine-Threonine Kinases; Receptor Protein-Tyrosine Kinases; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin; Virulence Factors | 2019 |
Comparison of acute kidney injury and clinical prognosis of vancomycin monotherapy and combination therapy with beta-lactams in the intensive care unit.
Topics: Acute Kidney Injury; Adult; beta-Lactams; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Humans; Intensive Care Units; Male; Middle Aged; Prognosis; Risk Factors; Survival Analysis; Vancomycin | 2019 |
Reply to Kollef et al.
Topics: Acute Kidney Injury; beta-Lactams; Critical Illness; Humans; Incidence; Vancomycin | 2020 |
Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2020 |
An Analysis of Resistance Patterns of Oral Streptococci Obtained from Orofacial Infections Against Beta-lactams, Clindamycin and Vancomycin over 2014-2018.
Topics: Anti-Bacterial Agents; beta-Lactams; Clindamycin; Humans; Microbial Sensitivity Tests; Retrospective Studies; Streptococcal Infections; Streptococcus; Vancomycin | 2019 |
Antimicrobial dosing in critical care: A pragmatic adult dosing nomogram.
Topics: Anti-Bacterial Agents; beta-Lactams; Critical Care; Humans; Microbial Sensitivity Tests; Nomograms; Vancomycin | 2020 |
The burden of antibiotic allergies in adults in an Australian intensive care unit: the BASIS study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Australia; beta-Lactams; Case-Control Studies; Drug Hypersensitivity; Female; Humans; Intensive Care Units; Prevalence; Prospective Studies; Vancomycin | 2019 |
Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Centers for Medicare and Medicaid Services, U.S.; Early Diagnosis; Early Medical Intervention; Emergency Service, Hospital; Female; Guideline Adherence; Hospital Mortality; Hospitalization; Humans; Male; Medical Overuse; Meropenem; Middle Aged; Patient Care Bundles; Piperacillin, Tazobactam Drug Combination; Reimbursement Mechanisms; Retrospective Studies; Sepsis; Shock, Septic; Soft Tissue Infections; Time-to-Treatment; United States; Urinary Tract Infections; Vancomycin | 2020 |
Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: Not Ready for Prime Time.
Topics: Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
In MRSA bacteremia, adding a β-lactam to usual care did not improve a composite outcome at 90 days.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2020 |
Combinations of (lipo)glycopeptides with β-lactams against MRSA: susceptibility insights.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Glycopeptides; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2020 |
Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2021 |
Penicillin versus anti-staphylococcal beta-lactams for penicillin-susceptible Staphylococcus aureus blood stream infections: a retrospective cohort study.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Female; Humans; Male; Penicillins; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2022 |
"The Early Beta-Lactam Catches the Germ": Empiric Antimicrobial Sequence in Bloodstream Infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Humans; Lactams; Sepsis; Vancomycin | 2022 |
Administration of a β-Lactam Prior to Vancomycin as the First Dose of Antibiotic Therapy Improves Survival in Patients With Bloodstream Infections.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Humans; Lactams; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2022 |
Antibiotic Optimization in the Intensive Care Unit.
Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Glycopeptides; Humans; Methicillin; Nafcillin; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2022 |
Divergent Effects of Peptidoglycan Carboxypeptidase DacA on Intrinsic β-Lactam and Vancomycin Resistance.
Topics: Alanine; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carboxypeptidases; Escherichia coli; Peptidoglycan; Vancomycin; Vancomycin Resistance | 2022 |
Antibiotic therapy does not alter mitochondrial bioenergetics in lymphocytes of patients with septic shock - A prospective cohort study.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clavulanic Acid; Energy Metabolism; Humans; Lymphocytes; Meropenem; Mitochondria; Piperacillin, Tazobactam Drug Combination; Polymyxins; Prospective Studies; Shock, Septic; Vancomycin | 2022 |
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin | 2023 |
Development of Whole-Cell Biosensors for Screening of Peptidoglycan-Targeting Antibiotics in a Gram-Negative Bacterium.
Topics: Agar; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Biosensing Techniques; Cell Wall; Cycloserine; Gram-Negative Bacteria; Luciferases, Bacterial; Membrane Transport Proteins; Peptidoglycan; Shewanella; Vancomycin | 2022 |
Genotypic characterization of vancomycin-resistant
Topics: Anti-Bacterial Agents; beta-Lactams; Cross-Sectional Studies; Erythromycin; Fluoroquinolones; Genotype; Gentamicins; Humans; Linezolid; Pristinamycin; Teicoplanin; Tigecycline; Urinary Tract Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Monobactams; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Antibiotic-Induced Neutropenia in Patients Receiving Outpatient Parenteral Antibiotic Therapy: a Retrospective Cohort Study.
Topics: Ambulatory Care; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cloxacillin; Humans; Neutropenia; Outpatients; Retrospective Studies; Vancomycin | 2023 |
The gastrointestinal antibiotic resistome in pediatric leukemia and lymphoma patients.
Topics: Anti-Bacterial Agents; beta-Lactams; Child; Gastrointestinal Tract; Genes, Bacterial; Humans; Leukemia; Lymphoma; Vancomycin | 2023 |
Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study.
Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Drug Monitoring; Humans; Vancomycin | 2023 |